Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer’s disease?

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.10, 2003-10, pp. : 1857-1860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease

By Plosker Greg L. Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 193-206

Adis International

Access to resources Recommend Favorite

Pharmacological treatment in moderate-to-severe Alzheimer's disease

By Hsiung Ging-Yuek Robin Feldman Howard H

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2575-2582

Informa Healthcare

Access to resources Recommend Favorite

Added Therapeutic Value of Memantine in the Treatment of Moderate to Severe Alzheimer's Disease

By Heinen-Kammerer T. Rulhoff H. Nelles S. Rychlik R.

Clinical Drug Investigation, Vol. 26, Iss. 6, 2006-01 ,pp. : 303-314

Adis International

Access to resources Recommend Favorite

Spotlight on Memantine in Moderate to Severe Alzheimer's Disease†

By McKeage Kate

Drugs & Aging, Vol. 27, Iss. 2, 2010-02 ,pp. : 177-179

Adis International

Access to resources Recommend Favorite

Evaluation of memantine for the treatment of Alzheimer’s disease

By Ferris Steven H

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2305-2313

Informa Healthcare

Access to resources Recommend Favorite